34 phd-computer-engineering-"Diamond-Light-Source"-"Diamond-Light-Source" Postdoctoral positions at Yale University in United States
Sort by
Refine Your Search
-
). Below are key aspects of the training program: The Yale CPC Training Program aims to train pre- and post-doctoral fellows in five thematic areas: cancer etiology, cancer outcomes, lifestyle behavioral
-
doctoral degree in epidemiology, biostatistics, computer science, engineering, environmental health sciences, social and behavioral sciences, health policy, medicine, or other areas in life or data sciences
-
Postdoctoral Associate in the Department of Biomedical Informatics & Data Science (BIDS), Yale School of Medicine Job Description We seek full-time Postdoctoral Associates in the areas of highly
-
Postdoctoral Associate in the Department of Biomedical Informatics and Data Science (BIDS), with Lucila Ohno-Machado, Yale University Job Description We seek full-time Postdoctoral Associates (two
-
lab can be found here: https://clinicalnlp.org/. Qualifications and Skills: • A PhD in computer science, information science, informatics, biomedical informatics, or related field. • Strong knowledge
-
Carbon Capture (YCNCC) is accepting applications for its Postdoctoral Fellowship Program. The YCNCC was established in 2021 to advance fundamental and applied science on enhancing natural Earth systems
-
. This position is 100% on site in New Haven, Connecticut. Candidate requirements Candidates must have a PhD in Biomedical Informatics, Data Science, Computer Science, or an informatics/engineering-related field
-
are invited for a Postdoctoral Associate specialised in Computational Biology to join the research group of Dr Sarah Aitken (MBChB PhD) in the Center of Molecular and Cellular Oncology, Yale Cancer Center
-
, communications, and updates. Required Education and Experience PhD Degree in computer science, applied/computational mathematics, engineering, bioinformatics, data science, or a related field and two years
-
highly motivated to impact patient outcomes through translational approaches to the treatment of T cell malignancies. Experience with in vivo mouse immunotherapy models, protein/antibody engineering and